Download PDFPDF

Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Challenges in reviewing methamphetamine-associated psychosis
    • Shalini Arunogiri, Psychiatrist Monash University; Turning Point, Eastern Health
    • Other Contributors:
      • Dan I. Lubman, Professor of Addiction Studies

    Stuart and colleagues protocol for a systematic review of psychological treatment for methamphetamine use [1] is a timely and relevant response to a significant gap in guidance for treatment of psychological sequelae arising from psychostimulant use. Given that levels of psychological distress and clinical mental health symptoms are very common in people who use methamphetamine, there is an urgent need for psychological treatment guidelines for this population.

    While many psychological interventions to date have also targeted comorbid anxiety and depressive symptoms, psychotic symptoms are also highly prevalent, clinically challenging and often poorly addressed. Methamphetamine-associated psychosis has been associated with significant morbidity, including increased agitation and violence, presentation to acute health services, and considerable health service burden [2]. A subset of individuals may also be at risk of developing more persistent psychotic symptoms, later transitioning to a diagnosis of chronic psychotic disorder.

    To date, the presence of psychotic symptoms has either been excluded, or not routinely screened for, in the majority of studies of psychological treatment for methamphetamine use. For instance, some studies have excluded participants with recent antipsychotic medication use[3], while measurement of psychotic symptoms or clinical assessments of psychotic disorder are typically absent [4-7]. On the other hand, many pharmacological inte...

    Show More
    Conflict of Interest:
    None declared.